Evaluating Newly Approved Drugs in Combination Regimens for Multidrug-Resistant TB With Fluoroquinolone Resistance (endTB-Q)

Clinical trial NCT03896685 · COMPLETED

Trial details

NCT number: NCT03896685
Sponsor: Médecins Sans Frontières, France
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Tuberculosis, Multidrug-Resistant Tuberculosis Pulmonary Tuberculoses Mycobacterial Infections Bacterial Infections Gram-Positive Bacterial Infections

Start date: 2020-04-06
Primary completion: 2024-10-04
Enrollment: 323

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.